INVESTOR AB Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0000889232

What is a 13F filing? Who files one and when · What 13F filings can't tell you

LargeFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 7 positions · Total reported value $13.72B · Top-10 concentration 100.0% · Updated 2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

Turnover: 37.5% · 1 new · 1 cut · 1 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.7% · vs SPY -6.9% · Prev Value $14.40B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +15.5% · vs SPY +13.4% · Latest Value $13.72B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, INVESTOR AB disclosed 7 equity positions with a combined reported value of $13.72B. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Large / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were AZN ($8.33B), NDAQ ($5.38B), MDWD ($12.01M). By sector, the heaviest allocations are Health Care 60.8%, Financials 39.2%. Versus the prior quarter, allocation shifted toward Financials (+7.2pp) and away from Health Care (-7.2pp).

Versus the prior quarter, INVESTOR AB opened 1 new positions, trimmed 1 and fully exited 1, a turnover rate of 37.5% of positions. The portfolio's overlap with the prior quarter was 75% of names.

The largest new positions opened in Q3 2026 were COHR ($863.43K).

Of the 1 positions fully exited versus the prior quarter, the largest were CLBT ($1.09M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • COHR COHERENT CORP · $863.43K

Fully Exited (vs previous quarter)

  • CLBT CELLEBRITE DI LTD · prev qtr: $1.09M

Insider Transactions (Form 4)

Latest INVESTOR AB buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-06-11 Buy NASDAQ, INC. 56,782 $85.98 SEC filing

All insider transactions →

Fund Profile

Investor AB is an SEC-registered 13F filer. As of Q3 2026 it reported 7 US equity positions with a combined value of $13.72B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 7 positions · $13.72B reported value (Q3 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: AZN (ASTRAZENECA PLC) at 60.7%
  • Average position size: $1.96B

Sector Tilt

  • Health Care 60.8%
  • Financials 39.2%
  • Information Technology 0.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 1 new, 1 added, 1 reduced, 1 exited
  • 4 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund reduced exposure to AstraZeneca (down 7.21% weight) and increased exposure to Nasdaq (up 7.21% weight), suggesting a shift from healthcare to tech/financials, while making minor adjustments in other sectors. 2. Key moves: - Added: Verizon (VZ, +19.5% shares, new 0.01% weight). - Reduced: Micron Technology (MU, -50.0% shares, weight unchanged at 0.00%). - New position: Coherent (COHR, 0.01% weight). 3. Portfolio structure: Active (benchmarks unclear), tilted toward Healthcare (60.71%) and Financials (39.19%), with modest tech exposure; moderate risk (concentrated top 2 holdings). 4. Per-holding one-liner: - AZN: AstraZeneca PLC (Healthcare, unverified benchmark). - NDAQ: Nasdaq Inc (Financials, unverified benchmark). - MDWD: MediWound Ltd (Healthcare, unverified benchmark). - COHR: Coherent Corp (Technology, unverified benchmark). - VZ: Verizon Communications Inc (Communication Services, unverified benchmark). - MU: Micron Technology Inc (Technology, unverified benchmark). - BMRN: BioMarin Pharmaceutical Inc (Healthcare, unverified benchmark). 5. Style summary: The fund tactically rotated from healthcare to financials/tech while making minor new additions and reductions.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 09:24

Sector Allocation

Health Care 60.8%
Financials 39.2%
Technology 0.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 51.59M $8.33B 60.71%
60.71%
Hold
2 58.44M $5.38B 39.19%
39.19%
Hold
3 872.09K $12.01M 0.09%
0.09%
Hold
4 3.00K $863.43K 0.01%
0.01%
New
5 13.50K $619.25K 0.01%
0.01%
Add
6 235 $250.30K 0.00%
0.00%
Reduce
7 3.70K $222.00K 0.00%
0.00%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 86% R 86% F1 86% (modelled on 2026-Q2; 6/10 hit)

Low-confidence forecast This fund replaces about 25% of its Top-10 each quarter and backtests at F1 76% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 76% · recall 78% · F1 76% · avg rank error 2.7 · Top-10 turnover 25%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 80% 80% 80% NDAQ · MU · AMZN · SWK · CCL · AMAT · ANET · CGNX · CHKP · AGRX NDAQ · MU · AMAT · ONTO · CHKP · ANET · CCL · COHR · CGNX · AGRX
2024-Q2 60% 100% 75% NDAQ · MU · AMAT · ANET · CHKP · ONTO · CCL · CGNX · COHR · AGRX NDAQ · ONTO · CHKP · CCL · COHR · CGNX
2024-Q3 100% 86% 92% NDAQ · CHKP · ONTO · CCL · CGNX · COHR NDAQ · MDWD · CHKP · ONTO · COHR · CCL · CGNX
2024-Q4 71% 62% 67% NDAQ · MDWD · CHKP · ONTO · CCL · COHR · CGNX NDAQ · MDWD · CHKP · CLBT · CCL · COHR · BLK · MCHP
2025-Q1 100% 80% 89% NDAQ · MDWD · CHKP · CCL · CLBT · COHR · MCHP · BLK NDAQ · MDWD · TIGO · CDNS · MCHP · CHKP · CLBT · COHR · BLK · CCL
2025-Q2 90% 90% 90% NDAQ · MDWD · TIGO · CHKP · MCHP · CDNS · CCL · COHR · BLK · CLBT NDAQ · MDWD · MCHP · TIGO · CDNS · CHKP · CLBT · CCL · COHR · TER
2025-Q3 70% 70% 70% NDAQ · MDWD · MCHP · TIGO · CCL · CHKP · COHR · CLBT · CDNS · WHR NDAQ · MDWD · MCHP · TER · CHKP · CLBT · CCL · ORCL · KYIV · WHR
2025-Q4 60% 60% 60% NDAQ · MDWD · MCHP · TER · CHKP · CCL · CLBT · WHR · ORCL · KYIV NDAQ · MDWD · COF · COHR · CLBT · CHKP · CRSR · CCL · QBTS · WHR
2026-Q1 60% 60% 60% NDAQ · MDWD · COHR · CHKP · CLBT · COF · CCL · QBTS · CRSR · BMRN AZN · NDAQ · MDWD · CLBT · COHR · KYIV · VZ · CRSR · WHR · BMRN
2026-Q2 60% 86% 71% AZN · NDAQ · MDWD · CLBT · COHR · BMRN · WHR · KYIV · CRSR · VZ AZN · NDAQ · MDWD · CLBT · MU · VZ · BMRN
2026-Q3 ★ 86% 86% 86% AZN · NDAQ · MDWD · CLBT · BMRN · VZ · MU AZN · NDAQ · MDWD · COHR · VZ · MU · BMRN

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-16. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-16 Trading days33 Holdings4 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.

Portfolio return+13.96%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+30.97%vs benchmark
Barra annualised vol36.2%Model estimate
Realised vol29.5%Annualised in window
Weighted beta0.25Raw exposure
Factor / specific risk38% / 62%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)77.388.098.8109.5120.310-0110-2311-16INVESTOR ABQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+13.96%Disclosed long book
QQQ synthetic benchmark-17.01%Liquidity-weighted constituents
Model universe, equal weight-1.70%Opportunity-cost reference
Excess return+30.97%Portfolio − benchmark
Arithmetic return sum+13.63%Difference vs compounded is the cross term
Weighted raw beta0.25Weighted holding betas
Realised volatility (annualised)29.50%Daily returns in window
Barra model volatility (annualised)36.24%Factor + specific
Factor share of variance37.9%Barra factors
Specific share of variance62.1%Stock residuals
Reported value$8.33B13F long US equity

2. Return attribution

The +13.63% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 +3.66% 26.8%
Momentum & Growth 3 -0.89% -6.6%
Volatility & Tail Risk 7 +3.10% 22.8%
Industry 12 +6.98% 51.2%
Specific 1 +0.79% 5.8%
Return attribution (style + industry, %)-7.5-3.8+0.0+3.8+7.5Non-linear Size-0.43Max Drawdown-0.45Residual Volatility-0.50Size+0.54Momentum+0.79Leverage (Downside Vol)-1.06Growth-1.49Turnover+1.57Mid Cap+1.76Kurtosis-1.87Beta-2.83Skewness+3.79Historical Volatility+6.03Health Care+6.98
Factor Type Exposure Factor return Contribution Share of |return|
Health Care Industry +1.00 +6.98% +6.98% 51.2%
Historical Volatility Style -0.43 -14.00% +6.03% 44.2%
Skewness Style -0.86 -4.39% +3.79% 27.8%
Mid Cap Style -0.91 -1.94% +1.76% 12.9%
Turnover Style -0.33 -4.80% +1.57% 11.5%
Specific Specific — — +0.79% 5.8%
Momentum Style -0.20 -4.00% +0.79% 5.8%
Size Style -0.28 -1.95% +0.54% 4.0%
Amihud Illiquidity Style -0.86 -0.45% +0.38% 2.8%
Liquidity Style -0.49 +0.36% -0.17% -1.3%
Short-term Reversal Style -0.22 +0.87% -0.19% -1.4%
Non-linear Size Style -0.42 +1.01% -0.43% -3.1%
Max Drawdown Style +0.26 -1.76% -0.45% -3.3%
Residual Volatility Style -0.15 +3.29% -0.50% -3.7%
Leverage (Downside Vol) Style +0.62 -1.71% -1.06% -7.8%
Growth Style -0.85 +1.75% -1.49% -10.9%
Kurtosis Style -0.25 +7.51% -1.87% -13.8%
Beta Style -0.64 +4.44% -2.83% -20.8%

3. Risk attribution

Annualised volatility is 36.24%; factor risk explains 37.9% of variance and specific risk 62.1%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-67.1-33.5+0.0+33.5+67.1Leverage (Downside Vol)-1.58Max Drawdown-1.19Skewness+0.29Historical Volatility+0.55Size+0.63Amihud Illiquidity+0.69Short-term Reversal+1.06Residual Volatility+1.09Mid Cap+1.17Liquidity+1.79Beta+4.73Growth+8.34Health Care+20.17Specific+62.09
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 62.1% +22.50% 22.5%
Health Care Industry +1.00 20.2% +7.31% 7.3%
Growth Style -0.85 8.3% +3.02% 3.0%
Beta Style -0.64 4.7% +1.71% 1.7%
Liquidity Style -0.49 1.8% +0.65% 0.7%
Mid Cap Style -0.91 1.2% +0.43% 0.4%
Residual Volatility Style -0.15 1.1% +0.39% 0.4%
Short-term Reversal Style -0.22 1.1% +0.38% 0.4%
Amihud Illiquidity Style -0.86 0.7% +0.25% 0.2%
Size Style -0.28 0.6% +0.23% 0.2%
Historical Volatility Style -0.43 0.6% +0.20% 0.2%
Skewness Style -0.86 0.3% +0.11% 0.1%
Max Drawdown Style +0.26 -1.2% -0.43% -0.4%
Leverage (Downside Vol) Style +0.62 -1.6% -0.57% -0.6%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-1.2-0.30.61.52.4Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.28 +2.10 -2.38
Non-linear Size -0.42 +1.68 -2.10
Mid Cap -0.91 +0.13 -1.04
Beta -0.64 +1.29 -1.93
Momentum -0.20 +0.72 -0.91
Short-term Reversal -0.22 -0.64 +0.43
Residual Volatility -0.15 -0.40 +0.25
Historical Volatility -0.43 +0.86 -1.29
Liquidity -0.49 +0.11 -0.60
Amihud Illiquidity -0.86 +1.16 -2.02
Turnover -0.33 +0.21 -0.53
Growth -0.85 +0.58 -1.44
Leverage (Downside Vol) +0.62 +0.14 +0.47
Skewness -0.86 +0.24 -1.10
Kurtosis -0.25 +0.21 -0.46
Max Drawdown +0.26 -0.08 +0.34

5. Industry allocation & Brinson

Industry allocation (weight, %)-10.020.050.080.0110.0UtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsCommunication ServicesInformation TechnologyHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% -30.03% -22.33% +3.83% -5.67% +5.67% +16.44%
Health Care 100.0% 1.7% +13.97% +8.29% +24.97% +0.10% +5.58% +13.82%
Communication Services 0.0% 2.6% +1.02% -17.64% +0.01% +0.49% -0.49% +0.46%
Utilities 0.0% 0.8% +0.00% +11.13% -0.22% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.26% -0.27% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +3.76% -1.84% -0.33% +0.33% -0.33%
Industrials 0.0% 11.1% +0.00% +4.36% -2.39% -0.48% +0.48% -0.48%
Total +23.98% -6.15% +11.83% +29.66%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
AZN ASTRAZENECA PLC Health Care 99.98% +13.96% +13.96% Hold
COHR COHERENT CORP Information Technology 0.01% -29.32% -0.00% New
VZ VERIZON COMMUNICATIONS INC Communication Services 0.01% +1.03% +0.00% Add
MU MICRON TECHNOLOGY INC Information Technology 0.00% -32.49% -0.00% Reduce
Contribution rank Symbol Sector Weight Return Contribution
1 AZN Health Care 99.98% +13.96% +13.96%
2 VZ Communication Services 0.01% +1.03% +0.00%
3 MU Information Technology 0.00% -32.49% -0.00%
4 COHR Information Technology 0.01% -29.32% -0.00%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned +13.96%, versus -17.01% for the QQQ synthetic benchmark — an excess of +30.97%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +6.98%, Historical Volatility +6.03%, Skewness +3.79%; the largest drags came from Beta -2.83%, Kurtosis -1.87%, Growth -1.49%. Specific (stock-level) return contributed +0.79%.
  3. Risk attribution: Barra model volatility is 36.24% annualised; factor risk explains 38% of variance and specific risk 62%. The largest factor risk sources are Health Care 20.2%, Growth 8.3%, Beta 4.7%.
  4. Style tilt: size -0.28, momentum -0.20, volatility -0.43, liquidity -0.49; the weighted raw beta is 0.25. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+98.3 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +23.98%, selection -6.15% and interaction +11.83%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did INVESTOR AB buy in 2026-Q3?

In its 2026-Q3 13F filing, INVESTOR AB reported 7 equity positions worth $13.72B in aggregate; its largest disclosed positions were AZN ($8.33B), NDAQ ($5.38B), MDWD ($12.01M).

How large is INVESTOR AB's portfolio?

INVESTOR AB reported $13.72B of long equity holdings across 7 positions as of 2026-Q3. Top-10 holdings account for 100.0% of reported value.

What is INVESTOR AB's investment style?

HoldingsHub classifies the portfolio as Large / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/investor-ab/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →